Should pituitary carcinoma be treated using a NET‐like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Should pituitary carcinoma be treated using a NET‐like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy
Authors
Keywords
-
Journal
CLINICAL ENDOCRINOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-12-01
DOI
10.1111/cen.14645
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
- (2020) Jacqueline Trouillas et al. Cancers
- Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
- (2020) Louis de Mestier et al. DIGESTIVE AND LIVER DISEASE
- Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature
- (2020) Laura Lizzul et al. Pituitary
- Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature
- (2020) Camille Duhamel et al. Journal of Personalized Medicine
- Aggressive Pituitary Adenomas and Carcinomas
- (2020) Mirela Diana Ilie et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor
- (2020) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
- (2020) Congxin Dai et al. Frontiers in Endocrinology
- Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
- (2020) Nazanin Majd et al. Journal for ImmunoTherapy of Cancer
- How and when to use temozolomide to treat aggressive pituitary tumours
- (2019) Ben C Whitelaw ENDOCRINE-RELATED CANCER
- A tale of pituitary adenomas: to NET or not to NET
- (2019) Ken K. Y. Ho et al. Pituitary
- Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab
- (2019) Mario Caccese et al. ANTI-CANCER DRUGS
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- (2017) S L Asa et al. ENDOCRINE-RELATED CANCER
- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now